Press Release - Ancillare, LP

Ancillare Strengthens Global Clinical Trial Supply Chain Leadership with Return of Chad Finney

Oct 9, 2025 | Press Release

HORSHAM, Pa. — October 9, 2025 Ancillare, the global leader in clinical trial ancillary supply chain management, is pleased to announce the return of Chad Finney as Senior Vice President of Business Development.

Finney brings over 15 years of experience in clinical trial supply and healthcare. He returns to Ancillare after serving as Vice President of Global Business Development at Adwin Scientific, Slope, and Orifarm Clinical Trial Supplies (formerly Pilatus Comparator Solutions), where he led strategic growth initiatives and strengthened client partnerships across the life sciences industry.

During his earlier tenure at Ancillare, Finney advanced from Business Development Manager to senior leadership, securing key clients that evolved into long-term strategic partnerships. He has built strong relationships with pharmaceutical and biotechnology companies, and leading CROs worldwide. Learn more about Ancillare’s global solutions.

In his new role, Finney will define and execute Ancillare’s global business development strategy, driving revenue growth, expanding partnerships, and strengthening the company’s global presence.

“We are thrilled to welcome Chad back to Ancillare,” said Joanne Santomauro, CEO. “His deep industry expertise and proven leadership will help us continue to grow and deliver exceptional value to our clients worldwide.”

Finney’s return reinforces Ancillare’s commitment to innovation, operational excellence, and client-focused partnership, solidifying its position as a trusted global partner for ancillary supply chain solutions supporting Sponsors, CROs, and research sites.

Ancillare Becomes a Global Distributor of Dexcom G7 Continuous Glucose Monitor (CGM) for Clinical Trials

Feb 4, 2025 | Press Release

HORSHAM, Pa. — February 4, 2025 Ancillare, the global leader in clinical trial supply chain solutions, is excited to announce its new role as a global distributor of the Dexcom G7 Continuous Glucose Monitor (CGM) for clinical trials. This cutting-edge device offers real-time, precise glucose data that will significantly improve study participant compliance, streamline decentralized trials, and reduce errors, making it an invaluable tool for clinical research.

The Dexcom G7 CGM provides accurate, continuous glucose monitoring, allowing healthcare professionals and researchers to access up-to-the-minute insights into participants’ glucose levels. This data enhances study design, increases operational efficiency, and focuses on participant well-being. It ensures that study participants’ glucose numbers are constantly monitored, anytime, anywhere, which is particularly crucial in decentralized and remote trials.

For Sponsors, accuracy and simplicity are paramount. for clinical trials. The Dexcom G7 CGM offers proven accuracy, enabling better -informed treatment decisions. By equipping study participants with this technology, Sponsors can allow participants to manage their diabetes with confidence while optimizing the trial process.

Through Ancillare’s comprehensive clinical trial supply services, Sponsors are supported with significant cost savings, optimize resource allocation, reduce risks, and improve overall coordination throughout the clinical trial supply chain. These capabilities, combined with the advanced technology of the Dexcom G7, ensure a streamlined and efficient clinical trial experience.

For more information about Ancillare and including Dexcom G7 CGM in your clinical trial, visit ancillare.com or contact us.

Ancillare Enhances Cold Chain Management Services for Clinical Trial Supplies

Jan 29, 2025 | Press Release

HORSHAM, Pa. — January 29, 2025 Ancillare, the global leader in clinical trial supply chain solutions, is pleased to announce the launch of its state-of-the-art Cold Chain Management services, specifically designed to ensure the safe handling and transport of temperature-sensitive supplies and equipment in clinical trials.

Recognizing the critical nature of temperature-sensitive products in clinical research, Ancillare is committed to maintaining precise refrigerated temperatures throughout the entire supply chain. This new service offering extends beyond transportation; it includes sourcing of the item, customs clearances, monitoring product expiry, and providing robust inventory management. These features are designed to guarantee the highest standards of quality, integrity and efficiency throughout the supply chain.

“Our enhanced Cold Chain Management services are a testament to Ancillare’s commitment to innovation and excellence in the clinical trial supply chain,” said Dr. Joanne Santomauro, CEO at Ancillare. “By offering a fully integrated approach that covers every aspect of the process – from sourcing to handling, storage, and transportation – we ensure that all products remain in optimal condition, while meeting stringent global regulatory requirements. This enables our Sponsors to avoid delays and disruptions that could negatively impact clinical trials.”

Ancillare’s comprehensive cold chain services help Sponsors achieve significant cost savings, optimize resource allocation, reduce risks, and improve overall coordination throughout the supply chain.

For more information about Ancillare and its Cold Chain Management services, see our Services page or request more information.

About Ancillare
Ancillare is a full-service clinical trial supply partner that Life Sciences companies of all sizes, and at all development stages, rely on. From startup to closeout, and from supply sourcing to equipment reclamation and study disposition, we are the pioneers in clinical trial ancillary supply consulting and management, experienced in the full spectrum of clinical trial life cycle variables.

The Ancillare Team leverages extensive global buying power, a vast depot network, and subject-matter experts in research, procurement, operations, logistics, and regulatory matters to create tailored clinical supply and equipment programs for the most demanding Phase I-IV clinical research.

We help executives achieve better operational efficiency at all levels of the trial value chain. Simplifying and streamlining supply processes —that’s our specialty. Reduced costs. Expedited cycle times. Risk well-managed. The benefits are measurable, but the results are invaluable.

Ancillare CEO Appointed to Serve on Supply Chain Management (SCM) Advisory Board at Temple University’s Fox School of Business

Aug 22, 2024 | Press Release

HORSHAM, Pa. — August 22, 2024 Ancillare, a global leader in global clinical trial supply chain solutions, proudly announces that Dr. Joanne Santomauro, Ancillare’s CEO, has been invited to serve on the Supply Chain Management (SCM) Advisory Board at Temple University esteemed Fox School of Business.

Joanne Santomauro brings over 40 years of experience in supply chain management and has been instrumental in the innovation and expansion of Ancillare’s Clinical Trial Ancillary Supply Chain (CTASC™) model. Since founding the company in 2006, Joanne’s leadership has propelled Ancillare to a prominent position in the global market.

Joanne holds advanced degrees, including a Doctorate in Business from the Temple University Fox School of Business. Her appointment to the SCM Advisory Board underlines Ancillare’s commitment to academic excellence and industry innovation.

Fox School of Business’s SCM program is renowned for its dynamic community of undergraduate and PhD students, guided by a faculty with nearly a century of collective industry experience. The SCM Advisory Board, consisting of supply chain executives from various industries, plays a crucial role in shaping the next generation of supply chain professionals.

“I am honored to serve as a board member for Fox School of Business’s SCM program”, said Dr. Joanne Santomauro. “As the demand for skilled supply chain professionals continues to grow, Fox School of Business is poised to be at the forefront of supply chain education and research.”

Dr. Santomauro’s expertise and leadership in clinical trial supply chain management will provide invaluable perspectives to the board, enhancing the curriculum and strengthening the bridge between academia and industry.

About Ancillare

Ancillare is the only full-service ancillary supply partner that Life Sciences companies of all sizes, and at all development stages, rely on. From start-up to closeout, and from supply sourcing to equipment reclamation and study dissolution, we are the pioneers in clinical trial ancillary supply consulting and management, experienced in the full spectrum of clinical trial life cycle variables.

The Ancillare Team leverages extensive global buying power, a vast depot network, and subject-matter experts in research, procurement, operations, logistics, and regulatory matters to create tailored ancillary supply and equipment programs for the most demanding Phase I-IV clinical research.

We help executives achieve better operational efficiency at all levels of the trial value chain. Simplifying and streamlining supply processes —that’s our specialty. Reduced costs. Expedited cycle times. Risk well-managed. The benefits are measurable, but the results are invaluable. To learn more, visit us at https://www.ancillare.com

Ancillare To Host Ribbon Cutting Ceremony, Unveil Multi-Million Dollar Renovation of Montgomery County Headquarters

May 9, 2023 | Press Release

The company invites staff and the press to tour its new Kitting facility for biopharmaceutical companies and CROs conducting global clinical research.

Horsham, Pa. — May 09, 2023. The Ribbon Cutting event will be by Ancillare on May 25, 2023 from 12-3 p.m. at the company’s headquarters, located at 700 Enterprise Road in Horsham, Pa.

Ancillare is the global leader and only Life Sciences company dedicated to ancillary supply and equipment management for Phase I-IV clinical research.

Renovations to the 80,000 square foot facility began in 2022 with its largest project being the creation of a cGMP compliant Kitting Room. The room will provide clinical kitting services, where custom collection kits are created based on the protocol needs of a particular clinical trial. Ancillare provides the equipment, packaging, instruction manuals, and compliant labeling.

In addition to the Kitting Room buildout, there were many eco-conscious improvements made throughout the facility.

The new Kitting Room joins Ancillare’s distribution and storage center in Horsham, 22 strategic depots located across Europe, South America, and Asia-Pacific, and its corporate office, which is also housed at the 700 Enterprise Road facility.

Jonathan Santomauro, Chief Strategy Officer, said, “Ancillare has always offered Kitting Services to our customers. But the dedicated Kitting Room we have built allows us to respond even faster to the demands of modern clinical research, providing our Sponsors unprecedented speed and flexibility in delivering single customized kits to the patients participating in these ground-breaking clinical trials.”

Ancillare employs over 115 people with employees working throughout Southeast Pennsylvania, across the United States and as far away as the Netherlands. The company plans to grow their workforce by 25% over the next several years.

The event will feature Ancillare’s Founding Partners and Executive Leadership, including Dr. Joanne Santomauro, Jason Monteleone, Jonathan Santomauro, and Frank Santomauro. Leadership Team members will be available for on-site interviews. If interested, the media is asked to contact Courtney Wright, Director of Global Marketing at courtney.wright@ancillare.com or by phone at 215-347-3916.

About Ancillare, LP
Ancillare is the only full-service ancillary supply partner that Life Sciences companies of all sizes, and at all development stages, rely on. From start-up to closeout, and from supply sourcing to equipment reclamation and study dissolution, we are the pioneers in clinical trial ancillary supply consulting and management, experienced in the full spectrum of clinical trial life cycle variables.

The Ancillare Team leverages extensive global buying power, a vast depot network, and subject-matter experts in research, procurement, operations, logistics, and regulatory matters to create tailored ancillary supply and equipment programs for the most demanding Phase I-IV clinical research.
We help executives and investors achieve better operational efficiency at all levels of the trial value chain. Simplifying and streamlining supply processes —that’s our specialty. Reduced costs. Expedited cycle times. Risk well-managed. The benefits are measurable, but the results are invaluable. To learn more, visit us at https://www.ancillare.com

Ancillare Launches Employee Training and Development Program, Offers Tuition Assistance

May 31, 2022 | Press Release

Leading life sciences supply chain organization announces new professional development resources for its staff.

Horsham, Pa. — May 31, 2022. Global Clinical Trial Ancillary Supply Chain (CTASC™) leader Ancillare, LP, the first and only Life Sciences company dedicated to Ancillary Supply Chain for Phase I-IV clinical research, is proud to announce the official launch of Ancillare University, a set of professional development courses for its staff.

Ancillare University includes a variety of resources for professionals at all levels, including Leadership and Executive courses, preparation for Project Management Certifications, Technology training, and more. The program became available to employees earlier this year and is fully accessible to its remote-first workforce.

In addition to the educational resources it offers internally, Ancillare also offers a tuition assistance program for employees advancing their careers through higher education.

“Ancillare University is designed to help our employees build more fulfilling, growth-oriented careers,” said Dr. Joanne Santomauro, Chief Executive Officer. “As an organization built on innovation, it is highly important that we continue to invest in our workforce.”

Ancillare is currently hiring for a variety of roles in Project Management, Clinical Operations, Procurement, Technology, and more. To learn more about open positions and available benefits, visit Ancillare.com/Careers.

About Ancillare, LP
Ancillare is the first and only Life Sciences company dedicated to Clinical Trial Ancillary Supply Chain (CTASC™) for Phase I-IV clinical research. Ancillare arms Sponsors of global clinical trials with customized, end-to-end supply plans, enabling developers of new therapies to optimize their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain.

Ancillare has supported more than 8,000 clinical trials across 550,000 clinical sites in over 100 countries with corporate offices in the United States and the Netherlands, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit Ancillare.com.